For more information call +1 412 595 0050
 

Noblia Advisors Resources

Emerging Markets Update

June 2017

Noblia Advisors' Emerging Markets Update. Published June 23, 2017

Global Business News

Noblia Advisors' recap of business news that matter from around the globe. Published June 23, 2017

Country Updates

Argentina

Open for Business Again

This January 2016 Noblia Advisors Country Update reviews key facts about the Argentine economy and new business opportunities under President Macri's administration. By Eduardo Campomar © Noblia Advisors.

News

Noblia Client Announcement

Noblia Advisors announces the expansion of its practice in South America through a partnerhip with Mr. Eduardo Campomar, Managing Director, Rainmaker Consulting. January, 2016.


Recommended Reading

Classics: Peter Drucker on Making Decisions

In this 2004 excerpt from the Harvard Business Review you can read in five minutes this legendary management consultant’s reflections on what makes an executive effective.

Global Economic Prospects

This June 2017 World Bank report discusses the current environment of a fragile global economic recovery. © World Bank Group, 2017.

Latin America Trade Trend Estimates

This May 2017 report by the Inter-American Development Bank (BID) presents Latin American and Caribbean International Trade Trend Estimates. © Inter-American Development Bank.

Income Polarization in the United States

This March 2017 IMF Research Bulletin discusses the implications of a shrinking middle-class and its effect on consumption. By Ali Alichi, Kory Kantenga, and Juan Solé. © International Monetary Fund.


In the news

CNN

Goldman Sachs slants research to help Democrats, top White House adviser says

Kevin Hassett, President Donald Trump's top economic adviser, suggested Goldman Sachs may be slanting its economic research to help Democrats ahead of the midterm elections.


Land O'Lakes CEO Beth Ford, from the cornfield to the C-suite

Land O'Lakes CEO Beth Ford charts her career path, from her first job to becoming the first openly gay CEO at a Fortune 500 company in an interview with CNN's Boss Files.


The next big test for Elon Musk arrives this week

Read full story for latest details.


The next big test for Elon Musk arrives this week

Read full story for latest details.

WSJ

Stocks Sink in Broad AI Rout Sparked by China's DeepSeek

U.S. stocks were mostly lower, with the Nasdaq leading declines as makers of AI infrastructure suffered steep falls, many in the double digits. Nvidia was down 16%.


Comex Gold, Silver Settle Lower

Gold settled 1.4% lower, down two of the past three sessions, and silver fell 2.5%, down three of the past four sessions.


DeepSeek Won't Sink U.S. AI Titans

Panic fueling the selloff of Nvidia, Broadcom and other tech giants is overblown.


Financial Services Roundup: Market Talk

Gain insight on Experian, SoFi Technologies and more in the latest Market Talks covering Financial Services.

BBC

Board of Peace's Gaza envoy criticises Israeli strikes and Hamas actions

Nickolay Mladenov warns that a collapse of last October's ceasefire would be "a point of no return" for the region.


Convicted Bosnian Serb war criminal Mladić dies aged 84

He was jailed for life in 2017 for genocide, war crimes and crimes against humanity during the wars in the ex-Yugoslavia in 1992-95.


The monstrous crimes of Ratko Mladic, the 'Butcher of Bosnia'

The Bosnian Serb commander led a campaign of ethnic cleansing during the Bosnian conflict.


'Silence is complicity' - top footballer hits out over Cameroon femicides

The killing of at least eight women in a week has sparked outrage in Cameroon.

NYT News

“Anxious Generation” Author Jonathan Haidt on the Meta Settlement

In “The Anxious Generation,” the sociologist laid out the evils of social media for kids. The landmark Meta settlement seems to agree.


Screwworm Flies Steer Clear of Agriculture Dept. Traps

No wild flies caught could mean the outbreak is contained. It could also mean, as scientists have said, that current trapping methods are outdated.


F.D.A. Approves the Drug Daraxonrasib That’s Poised to Transform Pancreatic Cancer

In a key clinical trial, patients who got the pill, daraxonrasib, lived twice as long as those who got chemotherapy.